Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amalie Dahl Haue

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Annual Review of Biomedical Data Science|August 23, 2024
Disease Trajectories from Healthcare Data: Methodologies, Key Results, and Future PerspectivesIsabella Friis Jørgensen, Amalie Dahl Haue, Davide Placido, et al.
The Lancet. Oncology|December 5, 2024
Artificial intelligence-aided data mining of medical records for cancer detection and screeningAmalie Dahl Haue, Jessica Xin Hjaltelin, Peter Christoffer Holm, et al.
Ugeskrift for Laeger|October 3, 2018
[Precision cardiology]Amalie Dahl Haue, Christoffer Rasmus Vissing, Jacob Tfelt-Hansen, et al.
NPJ Digital Medicine|October 21, 2021
Optimizing drug selection from a prescription trajectory of one patientAlejandro Aguayo-Orozco, Amalie Dahl Haue, Isabella Friis Jørgensen, et al.
The Lancet. Digital Health|April 23, 2026
Detection of young-onset type 2 diabetes using deep learning across primary and secondary care: a nationwide, retrospective cohort studyChristian Holm Johansen, Jessica Xin Hjaltelin, Davide Placido, et al.
PLOS Digital Health|September 7, 2023
Drug dosage modifications in 24 million in-patient prescriptions covering eight years: A Danish population-wide study of polypharmacyCristina Leal Rodríguez, Amalie Dahl Haue, Gianluca Mazzoni, et al.
British Journal of Cancer|September 16, 2021
Mapping of truncated O-glycans in cancers of epithelial and non-epithelial originTroels Boldt Rømer, Mikkel Koed Møller Aasted, Sally Dabelsteen, et al.
The Journal of Biological Chemistry|December 1, 2017
<i>De novo</i> expression of human polypeptide <i>N</i>-acetylgalactosaminyltransferase 6 (GalNAc-T6) in colon adenocarcinoma inhibits the differentiation of colonic epitheliumKirstine Lavrsen, Sally Dabelsteen, Sergey Y Vakhrushev, et al.
Elife|December 11, 2019
Linking glycemic dysregulation in diabetes to symptoms, comorbidities, and genetics through EHR data miningIsa Kristina Kirk, Christian Simon, Karina Banasik, et al.
Computational and Structural Biotechnology Journal|July 18, 2025
Genome-wide associations spanning 194 in-hospital drug dosage change phenotypes highlight diverse genetic backgrounds in concurrent drug therapyAlexander Pil Henriksen, Cristina Leal Rodríguez, Hannah Currant, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Annual Review of Biomedical Data Science|August 23, 2024
Disease Trajectories from Healthcare Data: Methodologies, Key Results, and Future PerspectivesIsabella Friis Jørgensen, Amalie Dahl Haue, Davide Placido, et al.
The Lancet. Oncology|December 5, 2024
Artificial intelligence-aided data mining of medical records for cancer detection and screeningAmalie Dahl Haue, Jessica Xin Hjaltelin, Peter Christoffer Holm, et al.
Ugeskrift for Laeger|October 3, 2018
[Precision cardiology]Amalie Dahl Haue, Christoffer Rasmus Vissing, Jacob Tfelt-Hansen, et al.
NPJ Digital Medicine|October 21, 2021
Optimizing drug selection from a prescription trajectory of one patientAlejandro Aguayo-Orozco, Amalie Dahl Haue, Isabella Friis Jørgensen, et al.
The Lancet. Digital Health|April 23, 2026
Detection of young-onset type 2 diabetes using deep learning across primary and secondary care: a nationwide, retrospective cohort studyChristian Holm Johansen, Jessica Xin Hjaltelin, Davide Placido, et al.
PLOS Digital Health|September 7, 2023
Drug dosage modifications in 24 million in-patient prescriptions covering eight years: A Danish population-wide study of polypharmacyCristina Leal Rodríguez, Amalie Dahl Haue, Gianluca Mazzoni, et al.
British Journal of Cancer|September 16, 2021
Mapping of truncated O-glycans in cancers of epithelial and non-epithelial originTroels Boldt Rømer, Mikkel Koed Møller Aasted, Sally Dabelsteen, et al.
The Journal of Biological Chemistry|December 1, 2017
<i>De novo</i> expression of human polypeptide <i>N</i>-acetylgalactosaminyltransferase 6 (GalNAc-T6) in colon adenocarcinoma inhibits the differentiation of colonic epitheliumKirstine Lavrsen, Sally Dabelsteen, Sergey Y Vakhrushev, et al.
Elife|December 11, 2019
Linking glycemic dysregulation in diabetes to symptoms, comorbidities, and genetics through EHR data miningIsa Kristina Kirk, Christian Simon, Karina Banasik, et al.
Computational and Structural Biotechnology Journal|July 18, 2025
Genome-wide associations spanning 194 in-hospital drug dosage change phenotypes highlight diverse genetic backgrounds in concurrent drug therapyAlexander Pil Henriksen, Cristina Leal Rodríguez, Hannah Currant, et al.
Pageof 1